VENTOLIN
LOE ApproachingNDAINHALATIONSOLUTION
Approved
Apr 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
2/8 — Basic
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ventolin is an inhaled albuterol solution, a beta-2 adrenergic agonist that relaxes airway smooth muscle by increasing cyclic AMP and inhibiting bronchoconstriction. It is a rapid-acting bronchodilator approved for asthma treatment with onset of action within 5 minutes and peak effect around 1 hour. The drug acts as a functional antagonist to protect against all bronchoconstrictor challenges irrespective of the underlying spasmogen.
LOE Approaching
As LOE approaches, Ventolin solution faces declining market share pressures from both branded alternatives and generic competition, signaling potential team consolidation and redeployment toward newer asthma mechanisms.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
Started Feb 2025
118 enrolled
Asthma
Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants
Started Apr 2023
28 enrolled
Asthma
A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer
Started Jan 2014
21 enrolled
Asthma
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
Started Mar 2009
17 enrolled
Asthma
Worked on VENTOLIN at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.